These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37038609)

  • 1. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors.
    Menéndez R; Méndez R; Latorre A; González-Jiménez P; Peces-Barba G; Molina M; España PP; García E; Consuegra-Vanegas A; Pando-Sandoval A; Panadero C; Figueira-Gonçalves JM; De la Rosa D; Sibila O; Martínez-Pitarch MD; Toledo N; Cejudo P; Almonte-Batista W; Macías-Paredes A; Badenes D; Pérez-Rodas EN; Lázaro J; Quirós S; Cordovilla R; Cano-Pumarega I; Torres A;
    J Intern Med; 2023 Jul; 294(1):69-82. PubMed ID: 37038609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.
    Bongiovanni M; Barilaro G; Bini F
    J Med Virol; 2023 Feb; 95(2):e28524. PubMed ID: 36695513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study.
    Faverio P; Luppi F; Rebora P; Busnelli S; Stainer A; Catalano M; Parachini L; Monzani A; Galimberti S; Bini F; Bodini BD; Betti M; De Giacomi F; Scarpazza P; Oggionni E; Scartabellati A; Bilucaglia L; Ceruti P; Modina D; Harari S; Caminati A; Valsecchi MG; Bellani G; Foti G; Pesci A
    Respiration; 2021; 100(11):1078-1087. PubMed ID: 34515212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge.
    Safont B; Tarraso J; Rodriguez-Borja E; Fernández-Fabrellas E; Sancho-Chust JN; Molina V; Lopez-Ramirez C; Lope-Martinez A; Cabanes L; Andreu AL; Herrera S; Lahosa C; Ros JA; Rodriguez-Hermosa JL; Soriano JB; Moret-Tatay I; Carbonell-Asins JA; Mulet A; Signes-Costa J
    Arch Bronconeumol; 2022 Feb; 58(2):142-149. PubMed ID: 34497426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.
    Strumiliene E; Zeleckiene I; Bliudzius R; Samuilis A; Zvirblis T; Zablockiene B; Strumila A; Gruslys V; Malinauskiene L; Kasiulevicius V; Jancoriene L
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204878
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous Evolution of COVID-19 Lung Sequelae: Results from a Double-Step Follow-Up.
    Ferioli M; Prediletto I; Bensai S; Betti S; Daniele F; Di Scioscio V; Modolon C; Rimondi MR; De Molo C; Serra C; Nava S; Fasano L
    Respiration; 2022; 101(4):381-393. PubMed ID: 35042222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months.
    Noel-Savina E; Viatgé T; Faviez G; Lepage B; Mhanna LT; Pontier S; Dupuis M; Collot S; Thomas P; Idoate Lacasia J; Crognier L; Bouharaoua S; Silva Sifontes S; Mazieres J; Prévot G; Didier A
    Respir Med Res; 2021 Nov; 80():100822. PubMed ID: 34242974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.
    Faverio P; Luppi F; Rebora P; D'Andrea G; Stainer A; Busnelli S; Catalano M; Modafferi G; Franco G; Monzani A; Galimberti S; Scarpazza P; Oggionni E; Betti M; Oggionni T; De Giacomi F; Bini F; Bodini BD; Parati M; Bilucaglia L; Ceruti P; Modina D; Harari S; Caminati A; Intotero M; Sergio P; Monzillo G; Leati G; Borghesi A; Zompatori M; Corso R; Valsecchi MG; Bellani G; Foti G; Pesci A
    Respir Res; 2022 Mar; 23(1):65. PubMed ID: 35313890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clinical symptoms, radiological changes and pulmonary function data 4 months after COVID-19.
    Labarca G; Henríquez-Beltrán M; Lastra J; Enos D; Llerena F; Cigarroa I; Lamperti L; Ormazabal V; Ramirez C; Espejo E; Canales N; Fuentes F; Horta G; Fernandez-Bussy S; Nova-Lamperti E
    Clin Respir J; 2021 Sep; 15(9):992-1002. PubMed ID: 34086416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study.
    Bellan M; Apostolo D; Albè A; Crevola M; Errica N; Ratano G; Tonello S; Minisini R; D'Onghia D; Baricich A; Patrucco F; Zeppegno P; Gramaglia C; Balbo PE; Cappellano G; Casella S; Chiocchetti A; Clivati E; Giordano M; Manfredi M; Patti G; Pinato DJ; Puricelli C; Raineri D; Rolla R; Sainaghi PP; Pirisi M;
    Front Immunol; 2022; 13():1038227. PubMed ID: 36601115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary long-term consequences of COVID-19 infections after hospital discharge.
    Blanco JR; Cobos-Ceballos MJ; Navarro F; Sanjoaquin I; Arnaiz de Las Revillas F; Bernal E; Buzon-Martin L; Viribay M; Romero L; Espejo-Perez S; Valencia B; Ibañez D; Ferrer-Pargada D; Malia D; Gutierrez-Herrero FG; Olalla J; Jurado-Gamez B; Ugedo J
    Clin Microbiol Infect; 2021 Jun; 27(6):892-896. PubMed ID: 33662544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19.
    Barisione G; Brusasco V
    Physiol Rep; 2021 Feb; 9(4):e14748. PubMed ID: 33625799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study.
    Schlemmer F; Valentin S; Boyer L; Guillaumot A; Chabot F; Dupin C; Le Guen P; Lorillon G; Bergeron A; Basille D; Delomez J; Andrejak C; Bonnefoy V; Goussault H; Assié JB; Choinier P; Ruppert AM; Cadranel J; Mennitti MC; Roumila M; Colin C; Günther S; Sanchez O; Gille T; Sésé L; Uzunhan Y; Faure M; Patout M; Morelot-Panzini C; Laveneziana P; Zysman M; Blanchard E; Raherison-Semjen C; Giraud V; Giroux-Leprieur E; Habib S; Roche N; Dinh-Xuan AT; Sifaoui I; Brillet PY; Jung C; Boutin E; Layese R; Canoui-Poitrine F; Maitre B;
    Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 36669777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual lung damage following ARDS in COVID-19 ICU survivors.
    Compagnone N; Palumbo D; Cremona G; Vitali G; De Lorenzo R; Calvi MR; Del Prete A; Baiardo Redaelli M; Calamarà S; Belletti A; Steidler S; Conte C; Zangrillo A; De Cobelli F; Rovere-Querini P; ; Monti G
    Acta Anaesthesiol Scand; 2022 Feb; 66(2):223-231. PubMed ID: 34758108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients.
    Philippe A; Günther S; Rancic J; Cavagna P; Renaud B; Gendron N; Mousseaux E; Hua-Huy T; Reverdito G; Planquette B; Sanchez O; Gaussem P; Salmon D; Diehl JL; Smadja DM
    Angiogenesis; 2024 Feb; 27(1):51-66. PubMed ID: 37526809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological and functional sequelae after COVID-19 pneumonia].
    Milos RI; Kifjak D; Heidinger BH; Prayer F; Beer L; Röhrich S; Wassipaul C; Gompelmann D; Prosch H
    Radiologe; 2021 Oct; 61(10):888-895. PubMed ID: 34529126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.